Dimeric diorganotin( iv ) complexes with arylhydrazones of β-diketones: synthesis, structures, cytotoxicity and apoptosis properties
Ten new dimeric diorganotin( iv ) complexes of the type [R 2 SnL] 2 (R = Me, Et, Bu, Ph or Oct, and H 2 L = arylhydrazones of β-diketone) have been obtained by the reaction of the corresponding arylhydrazone of β-diketone with diorganotin( iv ) dichloride under alkaline conditions. All the complexes...
Gespeichert in:
Veröffentlicht in: | RSC advances 2015-01, Vol.5 (56), p.45053-45060 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Ten new dimeric diorganotin(
iv
) complexes of the type [R
2
SnL]
2
(R = Me, Et, Bu, Ph or Oct, and H
2
L = arylhydrazones of β-diketone) have been obtained by the reaction of the corresponding arylhydrazone of β-diketone with diorganotin(
iv
) dichloride under alkaline conditions. All the complexes were characterized by elemental analysis, IR and NMR (
1
H,
13
C,
119
Sn) spectroscopies. Complexes
4
and
6
were also characterized by X-ray crystallography diffraction analysis, which revealed that the dimeric complexes have similar structures containing diorganotin(
iv
) skeletons formed by two weak but significant intermolecular Sn–O bonds. They were screened against the human tumor cell lines Hela, KB and HepG2. Complex
6
exhibited the highest
in vitro
cytotoxicity. The apoptosis induced by complexes
5
,
6
and
9
was quantified using a flow cytometric assay. All the three organotin(
iv
) compounds induced apoptosis much more effectively than
cis
platin, and the order of apoptosis induction is
6
>
5
>
9
>
cis
platin. The results indicate that the apoptosis induction of the compounds correlates with the cytotoxicity. Moreover, quantification data of apoptosis in KB cells suggests that the mechanism of cell death might occur mainly by means of early apoptosis at more than 0.25 μM concentration of the complexes, which is beneficial for an optimal antitumor agent. |
---|---|
ISSN: | 2046-2069 2046-2069 |
DOI: | 10.1039/C5RA06658A |